COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 2558: Articles 25571-25580  | Next

Effect of hydroxychloroquine on SARS-CoV-2 viral load in patients with COVID-19
Faico-Filho, K. S., Conte, D. D., Souza Luna, L. K., Carvalho, J. M. A., Perosa, A. H. S., Bellei, N.
10.1101/2020.06.16.20133066 — Posted: 2020-06-19
Standardized Testing Demonstrates Altered Odor Detection Sensitivity and Hedonics in Asymptomatic College Students as SARS-CoV-2 Emerged Locally
Walsh-Messinger, J., Kaouk, S., Manis, H., Kaye, R., Cecchi, G., Meyer, P., Malaspina, D.
10.1101/2020.06.17.20106302 — Posted: 2020-06-19
Distinct genetic spectrums and evolution patterns of SARS-CoV-2
Liu, S., SHEN, J., Yang, L., Hu, C.-D., Wan, J.
10.1101/2020.06.16.20132902 — Posted: 2020-06-19 Discussion: Onsite
Investigation of Compatibility of SARS-CoV-2 RT-PCR Kits Containing Different Gene Targets During COVID-19 Pandemic
Sarigul, F., Doluca, O., Akhan, S., Sayan, M.
10.1101/2020.06.17.20133967 — Posted: 2020-06-19
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
Farrera, L., Daguer, J.-P., Barluenga, S., Cohen, P. R., Pagano, S., Yerly, S., Kaiser, L., Vuilleumier, N., Winssinger, N.
10.1101/2020.06.15.20131391 — Posted: 2020-06-19
SEROPREVALENCE AND CLINICAL SPECTRUM OF SARS-CoV-2 INFECTION IN THE FIRST VERSUS THIRD TRIMESTER OF PREGNANCY
Crovetto, F., Crispi, F., Llurba, E., Figueras, F., Gomez-Roig, M. D., Gratacos, E.
10.1101/2020.06.17.20134098 — Posted: 2020-06-19
Two distinct immunopathological profiles in lungs of lethal COVID-19
Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M., Frank, A., Zsikla, V., Willi, N., Kempf, W., Hoyler, T., Barbareschi, M., Moch, H., Tolnay, M., Cathomas, G., Demichelis, F., Junt, T., Mertz, K. D.
10.1101/2020.06.17.20133637 — Posted: 2020-06-19 Discussion: Onsite | Offsite
Extrapolation of Infection Data for the CoVid-19 Virus in 21 Countries and States and Estimate of the Efficiency of Lock Down.
Langel, W.
10.1101/2020.06.17.20134254 — Posted: 2020-06-19
Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?
Borghi, M. O., Beltagy, A., Garrafa, E., Curreli, D., Cecchini, G., Bodio, C., Grossi, C., Blengino, S., Tincani, A., Franceschini, F., Andreoli, L., Lazzaroni, M. G., Piantoni, S., Masneri, S., Crisafulli, F., Brugnoni, D., Muiesan, M. L., Salvetti, M., Parati, G., Torresani, E., Mahler, M., Heilbron, F., Pregnolato, F., Pengo, M., Tedesco, F., Pozzi, N., Meroni, P. L.
10.1101/2020.06.17.20134114 — Posted: 2020-06-19
Downsides of face masks and possible mitigation strategies: a systematic review and meta-analysis
Bakhit, M., Krzyzaniak, N., Scott, A. M., Clark, J., Glasziou, P., Del Mar, C.
10.1101/2020.06.16.20133207 — Posted: 2020-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).